The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...

A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...

Staying on top of your health isn’t just about hitting the gym, eating well, or getting the necessary vaccines. It also means ...

Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...

Vascular graft rupture has occurred in patients treated with Symvess. Advise patients that arterial bleeding can be life-threatening and to seek emergent medical evaluation for any signs or symptoms ...

What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and ...

A high platelet count can lead to mild bruising or serious conditions like stroke. There are two types of thrombocytosis: primary, caused by genetic changes, and secondary, due to other conditions. If ...

Most experts would treat you for one to two weeks, then taper the medicine off over a few weeks. The side effects of this dose of steroids are modest if it does not need to be frequently repeated.

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.